secwatch.observer — SEC 8-K summary
======================================

Issuer:     BICYCLE THERAPEUTICS PLC (BCYC)
CIK:        0001761612
Form:       8-K
Filed at:   2026-02-03T23:59:59+00:00
Accession:  0001104659-26-009501
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bicycle Therapeutics appoints Travis Thompson as CFO, succeeding Alethia Young
------------------------------------------------------------------------------

- Travis Thompson appointed CFO effective Jan 29, 2026; previously SVP & Chief Accounting Officer since June 2023.
- Thompson receives $500K base salary, 50% target bonus, and 58,000 option shares under 2020 Equity Plan.
- Alethia Young steps down as CFO; remains in interim role through Apr 29, 2026, then as consultant for up to 3 years.
- Young eligible for 9 months severance, full 2025 bonus, pro-rated 2026 bonus, and 9 months COBRA.
- Thompson has no family relationships or related-party transactions with the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761612/000110465926009501/0001104659-26-009501-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761612/000110465926009501/tm264844d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-009501

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer